The treatment of AOSD have been progressed recently, and immunosuppressants, including methotrexate or cyclosporine and targeting therapy, such as IL-1 or IL-6 inhibitors, are available in addition to glucocorticoids (GCs)18. The gene discussed is IL1B; the disease is adult-onset Still disease.